Literature DB >> 18435577

On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84).

Armen H Tashjian1, David Goltzman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18435577     DOI： 10.1359/jbmr.080208

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  11 in total

1.  Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis.

Authors:  Erik R Sampson; Matthew J Hilton; Ye Tian; Di Chen; Edward M Schwarz; Robert A Mooney; Susan V Bukata; Regis J O'Keefe; Hani Awad; J Edward Puzas; Randy N Rosier; Michael J Zuscik
Journal:  Sci Transl Med       Date:  2011-09-21       Impact factor: 17.956

Review 2.  Parathyroid hormone analogues in the treatment of osteoporosis.

Authors:  Marius E Kraenzlin; Christian Meier
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

3.  Hypoparathyroidism: is it time for replacement therapy?

Authors:  Mara J Horwitz; Andrew F Stewart
Journal:  J Clin Endocrinol Metab       Date:  2008-09       Impact factor: 5.958

4.  Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.

Authors:  Karen K Winer; Andrea Kelly; Alicia Johns; Bo Zhang; Karen Dowdy; Lauren Kim; James C Reynolds; Paul S Albert; Gordon B Cutler
Journal:  J Pediatr       Date:  2018-12       Impact factor: 4.406

5.  Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo.

Authors:  P W M Ho; A Goradia; M R Russell; A M Chalk; K M Milley; E K Baker; J A Danks; J L Slavin; M Walia; B Crimeen-Irwin; R A Dickins; T J Martin; C R Walkley
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

6.  Present at the beginning: a personal reminiscence on the history of teriparatide.

Authors:  R Marcus
Journal:  Osteoporos Int       Date:  2011-03-31       Impact factor: 4.507

7.  Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.

Authors:  Karen K Winer; Bo Zhang; Joseph A Shrader; Donna Peterson; Michaele Smith; Paul S Albert; Gordon B Cutler
Journal:  J Clin Endocrinol Metab       Date:  2011-11-16       Impact factor: 5.958

Review 8.  Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches.

Authors:  Ernesto Canalis
Journal:  Nat Rev Endocrinol       Date:  2013-08-13       Impact factor: 43.330

Review 9.  Therapeutic Opportunities of Targeting Allosteric Binding Sites on the Calcium-Sensing Receptor.

Authors:  Jiayin Diao; Aaron DeBono; Tracy M Josephs; Jane E Bourke; Ben Capuano; Karen J Gregory; Katie Leach
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-08

Review 10.  Bone biology and anabolic therapies for bone: current status and future prospects.

Authors:  T John Martin
Journal:  J Bone Metab       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.